Navigation Links
Amnis Announces Release of Its Extended Depth of Field Option for The ImageStream(R) System
Date:5/22/2008

SEATTLE, May 22 /PRNewswire/ -- Amnis Corporation announced today the commercial release of its Extended Depth of Field (EDF(TM)) option for the ImageStream system. This technology breaks through classical depth of field limitations of high resolution optical systems, thereby improving the performance of the ImageStream system and enabling new applications including high speed analysis of fluorescence in-situ hybridization (FISH). The EDF option can be installed at time of manufacture or in the field to allow the existing customer base to take advantage of this new capability.

"The EDF option uses a combination of specialized optics and unique image processing algorithms to project all structures within the cell onto one crisp plane of focus," said William Ortyn, Amnis' Chief Operating Officer. "Until now this could only be accomplished via conventional confocal image stacking techniques which are very slow and tend to suffer from photo bleaching. The ImageStream with EDF is unhindered by photo bleaching and operates at rates close to 1000 times faster than confocal microscopy. The resulting imagery and analysis capabilities are unparalleled in the cell analysis space setting the stage for the development of fundamentally new research and clinical applications based on the ImageStream platform."

"To create the EDF upgrade we combined WaveFront Coded(TM) technology from [OmniVision-CDM Optics] with our own optimized image deconvolution algorithms, with striking results," said David Basiji, Ph.D., Amnis' President and CEO. "In addition to the optical benefits, the EDF option triples the data collection rate by allowing the instrument to be operated with a larger core stream diameter. One of the most important applications the ImageStream with EDF can now address is FISH in suspension (FISHIS(R)). Counting FISH spots accurately requires that all spots be in focus, no matter where they are in the nucleus ... EDF technology, combined with the tremendous speed and sensitivity of the ImageStream system, will make high throughput FISHIS a reality. With the recent release of IDEAS 3.0 and the current release of the EDF option, the Company continues to make excellent progress in advancing the technological capabilities of our product line.

Amnis Corporation, headquartered in Seattle, WA, develops, manufactures and markets the ImageStream system for high speed imaging of cells in flow. The system generates over 100,000 high resolution cell images per minute with fluorescence sensitivity better than standard flow cytometry. The ImageStream is supported by the IDEAS(R) image analysis package, a highly sophisticated yet easy to use tool for processing hundreds of thousands of images at a time. The software package enables advanced research applications in hematology, immunology and oncology, and provides a critical foundation for the company's clinical applications development.


'/>"/>
SOURCE Amnis Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amnis Announces the Release of Multiple Upgrades to the ImageStream(R) System
2. Amnis Announces Release of Powerful New Image Data Analysis Software
3. Amnis and Gene Company, Ltd. Announce Agreement to Market ImageStream Technology in China
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving ... marijuana products targeting the needs of consumers who are incorporating medical marijuana into ... in Phoenix, Arizona. , As operators of two successful Valley dispensaries, The Giving ...
(Date:10/6/2017)... , ... October 06, 2017 , ... ... within the healthcare and technology sector at their fourth annual Conference where founders, ... 30 inspiring speakers and the ELEVATE pitch competition showcasing early stage digital health ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... SEATTLE , April 5, 2017  The Allen ... the Allen Cell Explorer: a one-of-a-kind portal and dynamic ... large-scale 3D imaging data, the first application of deep ... edited human stem cell lines and a growing suite ... the platform for these and future publicly available resources ...
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
Breaking Biology News(10 mins):